PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'New Drug Discovery and Development, Biotheus Inc , Zhuhai, China.\', \'The Fifth Affiliated Hospital, Sun Yat-Sen University , Zhuhai, China.\', \'New Drug Discovery and Development, Hong Kong Science and Technology Park , China.\', \'Sir William Dunn School of Pathology, University of Oxford , Oxford, UK.\', \'Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford , Oxford, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/19420862.2020.1804241
?:doi
?:hasPublicationType
?:journal
  • mAbs
is ?:pmid of
?:pmid
?:pmid
  • 32804015
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.236
?:rankingScore_hIndex
  • 57
?:title
  • A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32804015>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32804015>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all